Chevallard Daniel R.

CFO Daniel R. Chevallard bought 7,500 LENZ shares at $8.57; stock now $8.29, down 83.1% from $49.05 high.

CFO Chevallard purchased 7,500 shares at $8.57 on 2026-03-27, increasing his holdings by 139.2% to 12,886 shares. The stock has declined 83.1% from its 52-week high of $49.05 and fallen 38.6% in the prior 30 days, trading near the low end of its range at $8.29. At LENZ specifically, Chevallard's two most recent prior buys (both on 2025-11-07) generated 30-day gains of approximately 17% but steep 90-day losses of roughly 38%, while his older buy (2024-05-14) proved well-timed with a 47.8% 90-day gain—only 1 of his 3 prior LENZ purchases showed sustained positive returns. The company is unprofitable with a $-16.7M net loss against $12.5M quarterly revenue, and notably, 2 other insiders also bought within the past 14 days. This cluster activity and CFO accumulation occur as the stock languishes far below recent highs, but his mixed track record at this ticker and the company's negative earnings provide context for assessing whether this represents fresh conviction or continuation of a pattern that has not consistently rewarded the executive's timing."

LENZ CFO Chevallard buys 2,198 shares ($50,016.99) at $22.76 avg; stock down 53.2% from peak, company unprofitable ($-16.7M net loss)

Daniel R. Chevallard, Chief Financial Officer of LENZ Therapeutics, completed 2 separate purchases totaling 2,198 shares (2.2K shares) for $50,016.99 on 2025-11-07 at a blended average price of $22.76. The transaction increases his shareholdings from 3,188 shares (3.2K shares) to 5,386 shares (5.4K shares), a 68.9% increase in position size. The buy occurs while the stock trades at $22.97 (current price), down 53.2% from its 52-week high of $49.05 and down 52.7% over the past 30 days, against a backdrop of company-wide unprofitability: latest quarter revenue of $12,500,000.00 ($12.5M) was offset by a net loss of $-16,700,000.00 ($-16.7M), with negative full-year net income as well. Chevallard's cross-ticker track record shows 1 prior buy with a 90d return of +47.8%, and at LENZ specifically, his prior buy on 2024-05-14 delivered a 90d return of +47.8%; however, past performance at this single company does not predict future outcomes in a materially deteriorating financial environment.